Gi Innovation, Inc.

This study is testing a new, experimental drug called GI-101 in people with advanced cancers that have spread. The main goals are to find a safe dose and see if the drug, given alone or with other approved cancer medicines, can help shrink tumors. The trial will enroll about 317 …

This early-stage study is testing a new drug called GI-108 in people with advanced or spreading solid tumors, including lung, head and neck, pancreatic, and kidney cancers. The main goals are to find a safe dose and see if the drug shows any signs of helping to shrink tumors. The…

This study is testing a two-part treatment (GI-102 and GIB-7) to see if it can improve signs of aging in the body. It will involve about 15 healthy adults and cancer survivors who will take the treatment or a placebo for 8 weeks. Researchers will measure changes in immune cells, …